...
首页> 外文期刊>Clinical and experimental ophthalmology >Pars plana insertion of glaucoma drainage devices for refractory glaucoma.
【24h】

Pars plana insertion of glaucoma drainage devices for refractory glaucoma.

机译:难治性青光眼的青光眼引流装置的pars平面插入。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Glaucoma drainage devices are more commonly inserted into the anterior chamber because of the relative ease of this method of insertion. However, in certain cases, posterior placement of the tube may be necessary or may be more desirable. The outcome of a series of patients with glaucoma drainage devices inserted into the pars plana was examined. METHODS: Retrospective chart review of patients who underwent pars plana implantation of Molteno and Baerveldt glaucoma drainage devices at the Sydney Eye Hospital. RESULTS: There were 33 cases reviewed. The mean follow-up period was 30.2 months. The mean final postoperative intraocular pressure was reduced to 13.4 +/- 4.4 mmHg (SD) from 33.06 +/- 8.47 mmHg preoperatively. The mean number of intraocular pressure-lowering medications in use postoperatively was 0.6 +/- 0.8, reduced from 3.6 +/- 1.27 medications in use preoperatively. Sixteen (48.5%) eyes were classified as complete successes, 14 (42.4%) eyes as qualified successes and three eyes (9%)as failures. Kaplan-Meier survival analysis for cumulative success (absence of failure) predicted 61.1% survival at 60 months. Complications included five cases of decompensation of corneas or corneal grafts, one case each of conjunctival wound dehiscence, large choroidal effusion, epiretinal membrane, Molteno plate extrusion and intraocular pressure unresponsive to medical therapy, and three cases of tube blockage. CONCLUSIONS: In this series of patients, pars plana insertion of glaucoma drainage devices has been shown to be an effective alternative for selected cases where anterior chamber tube insertion is not possible or is not ideal.
机译:背景:青光眼引流装置由于这种插入方法相对容易而更常插入前房。然而,在某些情况下,管子的后部放置可能是必要的,或者可能是更理想的。检查了一系列将青光眼引流装置插入睑缘的患者的结局。方法:回顾性图表回顾了在悉尼眼医院接受了平面内植入Molteno和Baerveldt青光眼引流装置的患者。结果:共33例。平均随访时间为30.2个月。术后最终平均眼压从术前的33.06 +/- 8.47 mmHg降低到13.4 +/- 4.4 mmHg(SD)。术后使用的眼内降压药物的平均数量为0.6 +/- 0.8,低于术前使用的3.6 +/- 1.27药物。十六眼(48.5%)的眼睛被归类为完全成功,十四眼(42.4%)的眼睛为合格,三眼(9%)的眼睛为失败。 Kaplan-Meier生存分析的累积成功(不存在失败)预测60个月生存率为61.1%。并发症包括五例角膜或角膜移植物代偿失调,结膜伤口裂开,大脉络膜积液,视网膜前膜,Molteno钢板挤压和眼压对药物治疗无反应的一例,以及三例管阻塞的病例。结论:在这一系列患者中,青光眼引流装置的平面pars插入已被证明是某些无法或不理想地插入前房管的病例的有效选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号